New test for diagnosing asthma using nasal swabs
Official title: NOVEL DIAGNOSTIC FOR MANAGING ASTHMA AT POINT OF CARE
Funded at Glycodots, LLC · NIH-11010248 · Data updated 2026-11-12
This study is working on a quick and easy test that uses a nasal swab to check for a substance related to asthma, helping doctors diagnose and manage the condition more effectively without any invasive procedures.
Quick facts
| Grant type | Sbir 1 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Glycodots, LLC NIH-funded |
| Lab location | 1 site (San Diego, United States) |
| Project start | September 1, 2024 |
| Project end | July 31, 2026 |
| Funding year | 2024 |
| Award (this year) | $288,043 |
| NIH project number | 1R43HL176373-01 |
| Project ID | NIH-11010248 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are children and young individuals under 11 years old who are experiencing asthma symptoms.
✕Less likely to help
Patients with asthma who are over 11 years old or those with non-eosinophilic asthma may not benefit from this research.
What this research studies
This research aims to develop a rapid diagnostic test that can detect eosinophil peroxidase (EPX) from nasal swab samples, providing a non-invasive way to diagnose and manage asthma. Currently, existing methods to measure EPX are often invasive or not readily available, making it difficult for patients to receive timely and accurate treatment. The new test will offer results comparable to the current gold standard, allowing healthcare providers to make informed decisions about asthma management at the point of care. By simplifying the diagnostic process, this research seeks to improve asthma care for patients.
Why it matters
Potential benefit: If successful, this research could lead to quicker and more accurate asthma diagnoses, improving treatment outcomes for patients.
How similar studies have gone: Previous research has shown success in developing diagnostic tests for asthma, but this specific approach using nasal swabs for EPX detection is novel.
Where this research is happening
-
Glycodots, LLC
San Diego, United States Active
Researchers
- Principal investigator: Svarovsky, Sergei a — Glycodots, LLC
- Study coordinator: Svarovsky, Sergei a
Related research
Other NIH-funded projects on the same topics.
-
GLP-1 receptor agonists as immune targets to treat asthma in lean and obese adults
Aims to understand how GLP-1R‑agonist diabetes medicines may directly calm immune cells to reduce asthma in adults who are lean or obese.
-
Understanding how a type of immune cell called ILC2s affect asthma in adults
This grant studies how group 2 innate lymphoid cells influence asthma in adults to help identify new ways to manage airway inflammation.
-
Expanding understanding of asthma in kids through airways and blood profiling
A study at UC San Francisco will profile blood and nasal/sputum samples from 300 youth (including 200 with asthma) over a year to understand how environmental and social factors influence asthma in marginalized communities.
-
Preventing and improving asthma care for children in urban communities
This program will try several approaches — from giving helpful bacteria to babies to allergy immunotherapy and advanced airway testing — to prevent and better treat asthma in children who live in cities.
-
IDEAL project helps predict vaccine response, infections, and asthma in early childhood
A Child-focused program will collect and share saliva, blood, and tissue samples from diverse infants to find biological patterns that predict how vaccines work, how respiratory infections occur, and who develops asthma.
-
Understanding how early-life immune development affects vaccine responses and asthma risk in children
This project uses lab-grown human immune cells from infants and young children to explore why some kids respond poorly to vaccines and are more prone to respiratory infections and asthma.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.